C12N 2795/14132
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2795/14132 (Use of virus as therapeutic agent, other than vaccine) appears on 20 US grants and 29 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 29
- Assignees
- 15
- Inventors
- 54
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 2 | 3 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 4 |
| 2019 | 0 | 3 |
| 2020 | 3 | 2 |
| 2021 | 3 | 2 |
| 2022 | 1 | 3 |
| 2023 | 2 | 3 |
| 2024 | 1 | 0 |
| 2025 | 2 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modular phage vector platform for sonodynamic therapy12 May 2026US 12,622,964 B2Alma Mater Studiorum - Università di Bologna
- Antibacterial phage, therapeutic composition, bactericidal agent, food, bacteria identification kit, therapeutic composition manufacturing method, bacteria elimination method, bacteria identification method, and animal therapeutic method23 Dec 2025US 12,502,413 B2Jichi Medical University
- M13 phage based gene therapy platform4 Nov 2025US 12,458,674 B2Massachusetts Institute of Technology
- Homogeneous engineered phage populations13 Feb 2024US 11,896,633 B2Massachusetts Institute of Technology
- Anti-angiogenin peptides, compositions, and methods of use12 Dec 2023US 11,839,642 B2The Board of Regents of the University of Oklahoma
- Antibacterial phage, therapeutic composition, bactericidal agent, food, bacteria identification kit, therapeutic composition manufacturing method, bacteria elimination method, bacteria identification method, and animal therapeutic method30 Apr 2026US 2026/0115243 A1Jichi Medical University
- Live biotherapeutics secreting synthetic bacteriophages in the treatment of cancer23 Nov 2023US 2023/0372419 A1Tatum Bioscience Inc.
- Phage-mediated delivery of genes to gut microbiome15 Jun 2023US 2023/0181659 A1CZ Biohub SF, LLC
- M13 phage based gene therapy platform9 Feb 2023US 2023/0041208 A1Massachusetts Institute of Technology
- Modular phage vector platform for sonodynamic therapy22 Sep 2022US 2022/0296710 A1Alma Mater Studiorum - Università di Bologna
Most cited
By later US patents
- Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia10US 7,867,487 B2Ramot at Tel-Aviv University Ltd. · 2011
- Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof4US 9,056,899 B2Massachusetts Institute of Technology · 2015
- Synthetic bacteriophages and bacteriophage compositions1US 10,626,394 B2Massachusetts Institute of Technology · 2020
- Bacteriophages expressing antimicrobial peptides and uses thereof1US 10,676,721 B2Massachusetts Institute of Technology · 2020
- Homogeneous engineered phage populations1US 10,987,388 B2Massachusetts Institute of Technology · 2021